Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

More Pharma Jobs Are Disappearing: Forest And Eisai Cut Back
Pharmalot
Monday, December 2, 2013 - 5:01pm
tags:
layoffs, Eisai, Forest Labs
Merck Faces Off Against Bristol-Myers' Yervoy
Motley Fool
Monday, December 2, 2013 - 5:00pm
tags:
Yervoy, Bristol-Myers Squibb, MK-3475, melanoma
Glivec Generics May Be Delayed In The U.S. - Buy Novartis
Seeking Alpha
Monday, December 2, 2013 - 4:58pm
tags:
Glivec, generics, Novartis, chronic myeloid leukemia
Why Did These 3 Biotechs Fail to Rally?
Motley Fool
Monday, December 2, 2013 - 4:57pm
tags:
Incyte, Questcor Pharmaceuticals, Acthar, Techne
4 Top-Performing Biotech IPOs of 2013
Minyanville
Monday, December 2, 2013 - 4:55pm
tags:
IPOs, biotech, INSYS Therapeutics, GW Pharma, Aratana, Alcobra
AIDS Group Sues Abbott And AbbVie Over 340B Drug Discounts
Pharmalot
Monday, December 2, 2013 - 11:49am
tags:
AIDS, Abbott Labs, 340B, AbbVie
PharmAthene scraps Theraclone merger after feds nix funding
Fierce Biotech
Monday, December 2, 2013 - 11:46am
tags:
PharmAthene, M&A, Theraclone
HeartWare buys CircuLite for up to $350M
Mass Device
Monday, December 2, 2013 - 11:45am
tags:
devices, Circulite, HeartWare, M&A
Arena's Belviq Script Sales Hit Milestones
Seeking Alpha
Monday, December 2, 2013 - 11:39am
tags:
Belviq, Eisai, Arena Pharmaceuticals
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Yahoo
Monday, December 2, 2013 - 10:17am
tags:
Saphris, schizophrenia, Forest Labs, Merck
Biogen Idec says FDA will allow 3 more months to review its hemophilia B drug Alprolix
Yahoo/AP
Monday, December 2, 2013 - 10:15am
tags:
Biogen Idec, FDA, hemophilia B, Alprolix
Baxter submits amended BLA to U.S. FDA for HyQvia
The Fly on the Wall
Monday, December 2, 2013 - 10:13am
tags:
Baxter International, FDA, HyQvia, Halozyme
Forest Labs Unveils Restructuring Plan
NASDAQ.com
Monday, December 2, 2013 - 9:51am
tags:
Forest Labs, restructuring, layoffs
Johnson & Johnson's Real Answer To Imminent Decline In Sales Of Top-Selling Drug
Seeking Alpha
Monday, December 2, 2013 - 9:45am
tags:
JNJ, Remicade, Olysio, hepatitis C
Is GlaxoSmithKline plc Set For Electrifying Earnings Growth In 2014?
Motley Fool
Monday, December 2, 2013 - 9:43am
tags:
GSK
The Growing Need For Outcome Studies And The Impact On R&D Costs
Forbes
Monday, December 2, 2013 - 9:42am
tags:
clinical outcomes, R&D, PCSK9 inhibitors
If Northwest Biotherapeutics Wins, It Wins Big
Seeking Alpha
Monday, December 2, 2013 - 8:44am
tags:
Northwest Biotherapeutics, DCVax, brain cancer, solid tumors
Biotech Stocks Partying Like It's 1999
TheStreet.com
Monday, December 2, 2013 - 8:42am
tags:
biotech
GSK says CEO's China visit flags commitment in face of graft scandal
Reuters
Monday, December 2, 2013 - 8:40am
tags:
GSK, China
Shire agrees to supply Adderall XR generic to Sandoz
Reuters
Monday, December 2, 2013 - 8:40am
tags:
Shire, generics, Sandoz, Novartis, ADHD, Adderall XR

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.